Joseph C. Glorioso

18.8k total citations · 1 hit paper
327 papers, 15.0k citations indexed

About

Joseph C. Glorioso is a scholar working on Epidemiology, Genetics and Molecular Biology. According to data from OpenAlex, Joseph C. Glorioso has authored 327 papers receiving a total of 15.0k indexed citations (citations by other indexed papers that have themselves been cited), including 206 papers in Epidemiology, 172 papers in Genetics and 90 papers in Molecular Biology. Recurrent topics in Joseph C. Glorioso's work include Herpesvirus Infections and Treatments (203 papers), Virus-based gene therapy research (170 papers) and Toxin Mechanisms and Immunotoxins (50 papers). Joseph C. Glorioso is often cited by papers focused on Herpesvirus Infections and Treatments (203 papers), Virus-based gene therapy research (170 papers) and Toxin Mechanisms and Immunotoxins (50 papers). Joseph C. Glorioso collaborates with scholars based in United States, Japan and Italy. Joseph C. Glorioso's co-authors include William F. Goins, Michael Levine, David J. Fink, Marina Mata, Mark A. Kay, Luigi Naldini, Darren Wolfe, D J Fink, Justus B. Cohen and James R. Goss and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Joseph C. Glorioso

322 papers receiving 14.3k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics

2001 997 citations Joseph C. Glorioso et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joseph C. Glorioso United States	67	6.4k	6.3k	5.3k	2.9k	2.1k	327	15.0k
Bruce H. Howard United States	39	6.0k 0.9×	1.9k 0.3×	15.6k 2.9×	3.6k 1.3×	849 0.4×	91	22.1k
Frank L. Graham Canada	69	14.3k 2.2×	3.9k 0.6×	17.7k 3.3×	4.0k 1.4×	930 0.4×	184	28.6k
Guangping Gao United States	77	14.5k 2.3×	2.8k 0.4×	16.6k 3.1×	2.0k 0.7×	1.1k 0.5×	355	24.7k
Ralf Kühn Germany	64	4.3k 0.7×	2.3k 0.4×	11.2k 2.1×	8.4k 2.9×	3.6k 1.7×	234	25.8k
Beverly L. Davidson United States	89	8.4k 1.3×	2.8k 0.4×	19.2k 3.6×	1.6k 0.5×	4.8k 2.3×	334	28.1k
A.J. van der Eb Netherlands	46	7.1k 1.1×	2.1k 0.3×	11.8k 2.2×	2.5k 0.8×	619 0.3×	140	18.1k
Michel Aguet Switzerland	58	1.9k 0.3×	2.7k 0.4×	9.8k 1.8×	10.8k 3.7×	1.0k 0.5×	121	23.9k
Nicholas Muzyczka United States	75	11.5k 1.8×	2.4k 0.4×	11.3k 2.1×	555 0.2×	3.2k 1.5×	155	18.2k
Mark A. Kay United States	98	17.3k 2.7×	2.7k 0.4×	25.5k 4.8×	1.9k 0.7×	1.1k 0.5×	296	33.4k
Keiko Ozato United States	93	3.4k 0.5×	2.1k 0.3×	14.7k 2.8×	13.5k 4.7×	1.1k 0.5×	332	28.8k

Countries citing papers authored by Joseph C. Glorioso

Since Specialization

Citations

This map shows the geographic impact of Joseph C. Glorioso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph C. Glorioso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph C. Glorioso more than expected).

Fields of papers citing papers by Joseph C. Glorioso

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph C. Glorioso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph C. Glorioso. The network helps show where Joseph C. Glorioso may publish in the future.

Co-authorship network of co-authors of Joseph C. Glorioso

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph C. Glorioso. A scholar is included among the top collaborators of Joseph C. Glorioso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph C. Glorioso. Joseph C. Glorioso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hall, Bonnie L., et al.. (2024). Viral vectors for gene delivery to the central nervous system. Handbook of clinical neurology. 205. 59–81.

Jackson, Joseph W., Bonnie L. Hall, Lisa Bailey, et al.. (2021). Treatment of glioblastoma with current oHSV variants reveals differences in efficacy and immune cell recruitment. Molecular Therapy — Oncolytics. 22. 444–453. 7 indexed citations

Wirsching, Hans‐Georg, Sonali Arora, Huajia Zhang, et al.. (2019). Cooperation of oncolytic virotherapy with VEGF-neutralizing antibody treatment in IDH wildtype glioblastoma depends on MMP9. Neuro-Oncology. 21(12). 1607–1609. 8 indexed citations

Mazzacurati, Lucia, et al.. (2018). A Novel Oncolytic Herpes Simplex Virus Design based on the Common Overexpression of microRNA-21 in Tumors. PubMed. 3(1). 1–8. 10 indexed citations

Shimizu, Nobutaka, William F. Goins, Katsumi Kadekawa, et al.. (2017). Morphological changes in different populations of bladder afferent neurons detected by herpes simplex virus (HSV) vectors with cell-type-specific promoters in mice with spinal cord injury. Neuroscience. 364. 190–201. 21 indexed citations

Verlengia, Gianluca, et al.. (2017). Engineered HSV vector achieves safe long-term transgene expression in the central nervous system. Scientific Reports. 7(1). 1507–1507. 35 indexed citations

Yokoyama, Hitoshi, Yasuhito Funahashi, Satoru Yoshikawa, et al.. (2013). Inhibition of bladder hypersensitivity by interleukin 4 (IL-4) gene therapy using herpes simplex virus (HSV) vectors in rats with cyclophosphamide induced cystitis. Neurourology and Urodynamics. 1 indexed citations

Yoo, Ji Young, Jason Pradarelli, Amy Haseley, et al.. (2012). Copper Chelation Enhances Antitumor Efficacy and Systemic Delivery of Oncolytic HSV. Clinical Cancer Research. 18(18). 4931–4941. 34 indexed citations

Dmitrieva, Nina, Lianbo Yu, Mariano S. Viapiano, et al.. (2010). Chondroitinase ABC I–Mediated Enhancement of Oncolytic Virus Spread and Antitumor Efficacy. Clinical Cancer Research. 17(6). 1362–1372. 70 indexed citations

10.

Trybala, Edward, Sigvard Olofsson, Bo Svennerholm, et al.. (2004). Structural and functional features of the polycationic peptide required for inhibition of herpes simplex virus invasion of cells. Antiviral Research. 62(3). 125–134. 19 indexed citations

11.

Koldamova, Radosveta, Iliya Lefterov, Matthias Staufenbiel, et al.. (2004). The Liver X Receptor Ligand T0901317 Decreases Amyloid β Production in Vitro and in a Mouse Model of Alzheimer's Disease. Journal of Biological Chemistry. 280(6). 4079–4088. 225 indexed citations

12.

Burton, Edward A., David J. Fink, & Joseph C. Glorioso. (2002). Gene Delivery Using Herpes Simplex Virus Vectors. DNA and Cell Biology. 21(12). 915–936. 69 indexed citations

13.

Trybala, Edward, et al.. (2001). Mutational analysis of the major heparan sulfate-binding domain of herpes simplex virus type 1 glycoprotein C. Journal of General Virology. 82(8). 1941–1950. 57 indexed citations

14.

Mi, Zhibao, Steven C. Ghivizzani, Eric R. Lechman, et al.. (2000). Adenovirus-mediated gene transfer of insulin-like growth factor 1 stimulates proteoglycan synthesis in rabbit joints. Arthritis & Rheumatism. 43(11). 2563–2570. 76 indexed citations

15.

Glorioso, Joseph C. & Martin C. Schmidt. (1999). Expression of recombinant genes in eukaryotic systems. Academic Press eBooks. 3 indexed citations

16.

Laquerre, Sylvie, William F. Goins, Shusuke Moriuchi, et al.. (1999). 8 Gene-transfer Tool: Herpes Simplex Virus Vectors. Cold Spring Harbor Monograph Archive. 36. 173–208. 6 indexed citations

17.

Huard, Johnny, et al.. (1996). The basal lamina is a physical barrier to herpes simplex virus-mediated gene delivery to mature muscle fibers. Journal of Virology. 70(11). 8117–8123. 69 indexed citations

18.

French, Samuel W., Martin C. Schmidt, & Joseph C. Glorioso. (1996). Involvement of a High-Mobility-Group Protein in the Transcriptional Activity of Herpes Simplex Virus Latency-Active Promoter 2. Molecular and Cellular Biology. 16(10). 5393–5399. 34 indexed citations

19.

Trybala, Edward, Tomas Bergström, Bo Svennerholm, et al.. (1994). Localization of a functional site on herpes simplex virus type 1 glycoprotein C involved in binding to cell surface heparan sulphate. Journal of General Virology. 75(4). 743–752. 93 indexed citations

20.

Weber, Peter, et al.. (1988). Inversion events in the HSV-1 genome are directly mediated by the viral DNA replication machinery and lack sequence specificity. Cell. 54(3). 369–381. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact